Mainz Biomed B.V. (MYNZ) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -8.95M | -8.14M | -4.66M | -5.12M | -8.31M | -6.46M | -3.09M | -228.77K | -234.37K | -234.37K | -104.12K | -104.12K |
| Operating CF Margin % | -2396.79% | -1563.97% | -2167.61% | -1023.32% | -3306.6% | -2318.62% | -1929.43% | -54.82% | -94.97% | -94.97% | -148.01% | -148.01% |
| Operating CF Growth % | -92.16% | -59.12% | 44% | 20.72% | -169.21% | -2722.47% | -1217.5% | 2.39% | -125.09% | -125.09% | - | - |
| Net Income | -10.63M | -11.02M | -5.18M | -8.25M | -13.78M | -12.6M | -11.43M | -240.75K | -293.45K | -293.45K | -239.26K | -239.26K |
| Depreciation & Amortization | 520.09K | 496.95K | 204.47K | 171.02K | 317.43K | 62.37K | 35.09K | 34.84K | 30.23K | 30.23K | 13.26K | 13.26K |
| Stock-Based Compensation | 108.05K | 1.03M | 818.99K | 2.1M | 4.14M | 5.68M | 6.43M | 1.61M | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | -17.54K | 0 | 0 | 0 | -6.49M | -1.74M | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.4M | 959.71K | -712.85K | 4.76K | 1.7M | 154.67K | 2.66M | 119.54K | 54 | 54 | 16.12K | 16.12K |
| Working Capital Changes | -342.23K | 393.98K | 235.08K | 1.78M | -683.83K | 246.44K | -784.16K | 11.98K | 28.79K | 28.79K | 105.76K | 105.76K |
| Change in Receivables | 129.23K | -64.95K | 101.23K | 58.9K | -163.86K | -47.37K | 56.54K | -32.33K | -49.58K | -49.58K | 84.91K | 84.91K |
| Change in Inventory | 21.54K | 8.27K | -158.13K | -121.05K | -134.11K | -38.27K | -670.73M | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 484.67K | -58.9K | 0 | 0 | 670.73M | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | 221.84K | -420.66K | -261.81K | -123.63K | -406.04K | -252.45K | 1.21M | -4.58K | -4.84K | -4.84K | 0 | 0 |
| Capital Expenditures | 15.71K | -120.66K | -174.29K | -123.63K | -406.04K | -252.45K | -12.13K | -4.58K | -4.84K | -4.84K | 0 | 0 |
| CapEx % of Revenue | 4.21% | 23.17% | 81.15% | 24.71% | 161.51% | 90.65% | 7.58% | 1.1% | 1.96% | 1.96% | - | - |
| Acquisitions | 32.78K | 0 | 0 | 0 | 0 | 0 | 1.22M | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 173.35K | -300K | -87.52K | -500K | 0 | 0 | 1.22M | 0 | 4.84K | 4.84K | 0 | 0 |
| Cash from Financing | 14.05M | 2.55M | 3.47M | 5.42M | -148.23K | 24.09M | 10.39M | 503K | -19.44K | -19.44K | -7.6K | -7.6K |
| Debt Issued (Net) | 1.09M | 2.04M | -1.97M | 4.39M | 0 | -45.69K | 0 | 217.03K | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 1000K | 0 | 1000K | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -810.52K | 515.26K | 934.87K | 0 | -148.23K | 24.14M | 10.39M | 0 | 19.44K | 19.44K | -7.6K | -7.6K |
| Net Change in Cash | 5.26M | 977.76K | -2.25M | 52.88K | -26.01M | 26.01M | 1.99M | 243.59K | -40.51K | -40.51K | -6.49K | -6.49K |
| Free Cash Flow | -9.08M | -8.27M | -4.92M | -5.24M | -8.72M | -6.71M | -3.1M | -233.35K | -239.21K | -239.21K | -104.12K | -104.12K |
| FCF Margin % | -2432.78% | -1587.14% | -2289.52% | -1048.04% | -3468.11% | -2409.28% | -1937% | -55.92% | -96.93% | -96.93% | -148.01% | -148.01% |
| FCF Growth % | -84.66% | -57.67% | 43.6% | 21.86% | -181.26% | -2775.26% | -1195.89% | 2.45% | -129.74% | -129.74% | - | - |
| FCF per Share | -9.38 | -14.79 | -11.12 | -0.18 | -0.62 | -0.47 | -0.35 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 |
| FCF Conversion (FCF/Net Income) | 0.84x | 0.74x | 0.90x | 0.39x | 0.66x | 0.47x | 0.27x | 0.95x | 0.80x | 0.80x | 0.44x | 0.44x |
| Interest Paid | 8.06K | 190K | 0 | 0 | 67.87K | 57.68K | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |